About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Colorado | 16,579 Studies Near You

Clinical TrialsColorado

Clinical Trials in Colorado

Discover 16,579 clinical trials near Colorado. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2641-2660 of 16,579 trials

UnknownVinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)This is an open-label, randomized, multi-center, comparator Phase II trial looking at the addition of Bevacizumab to Vinblastine in chemotherapy naïve pediatric patients with…NCT02840409·Los Angeles, California and 20 others CompletedDose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HClTo assess the efficacy of optimized Extended-release Guanfacine Hydrochloride compared with placebo in the treatment of adolescents aged 13-17 years with a diagnosis of ADHD as…NCT01081132·Dothan, Alabama and 53 others

Find Trials by Condition in Colorado

Breast Cancerin Colorado Lung Cancerin Colorado Prostate Cancerin Colorado Colorectal Cancerin Colorado Melanomain Colorado Leukemiain Colorado Lymphomain Colorado Pancreatic Cancerin Colorado Ovarian Cancerin Colorado Brain Cancerin Colorado Diabetes

Data from ClinicalTrials.govTerms

CompletedPatient-Centered Adherence Intervention After Acute Coronary Syndrome (ACS) HospitalizationWe propose to test the effectiveness of a multi-faceted patient-centered adherence intervention among veterans following ACS hospitalization to improve adherence to…NCT00903032·Little Rock, Arkansas and 3 others

RecruitingA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseThe study evaluates the safety of different doses of a new medicine called NNC0519 0130.NCT06717698·San Dimas, California and 146 others

CompletedDocetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerThis randomized phase III trial studies docetaxel, carboplatin, trastuzumab, and pertuzumab with estrogen deprivation to see how they work compared to docetaxel, carboplatin…NCT02003209·Fairbanks, Alaska and 731 others

CompletedA Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological MalignanciesThe Phase 1 portion of the study will evaluate the pharmacokinetic profile and safety of ABT-263 with the objective of defining the dose limiting toxicity and maximum tolerated…NCT00445198·Peoria, Arizona and 17 others

Active not recruitingA Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaThis is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an autologous dual targeting chimeric antigen receptor (CAR) T-cell therapy targeting both cluster of…NCT05421663·Duarte, California and 31 others

CompletedAn Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction CancerThe primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.NCT02743494·Tucson, Arizona and 203 others

RecruitingExtension Study for the Port Delivery System With Ranibizumab (Portal)This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular…NCT03683251·Phoenix, Arizona and 164 others

TerminatedImproving Mental Health Outcomes: Building an Adaptive Implementation StrategyThe overarching goal of this study is to build the most cost-effective adaptive implementation intervention involving a site-level implementation intervention strategy…NCT02151331·Denver, Colorado and 1 other

CompletedImpact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator TherapyDespite the increasingly common use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies in treating CF, it is still largely unknown whether or not…NCT04378153·Birmingham, Alabama and 79 others

CompletedStereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)\- Progression free survival after locally ablative therapy and erlotinib in EGFR patients progressed after EGFR-TKI therapyNCT01573702·San Francisco, California and 7 others

CompletedStudy Assessing Double-masked Uveitis TreatmentThe purpose of this study is to evaluate the safety and efficacy of intravitreal injections of DE-109 ophthalmic solution.NCT01358266·Phoenix, Arizona and 150 others

RecruitingTesting the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersThis phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer…NCT05408845·Birmingham, Alabama and 151 others

CompletedStudy to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy SubjectsThis Phase 1 open label study is being conducted to directly characterize the pharmacokinetic (PK) profiles of seladelpar following administration of a single oral dose in…NCT03369002·Lakewood, Colorado and 3 others

RecruitingEfficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemThis multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes…NCT07579702·Los Angeles, California and 10 others

SuspendedAutologous Incubated Macrophages for Patients With Complete Spinal Cord InjuriesAutologous Incubated Macrophages (ProCord) is being developed as a therapy for acute, complete spinal cord injury (SCI).NCT00073853·Englewood, Colorado and 6 others

RecruitingA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHThis is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with compensated cirrhosis due to NASH/MASH.NCT06528314·Birmingham, Alabama and 330 others

CompletedRegulation Of Maternal Fuel Supply And Neonatal AdiposityThe purpose of this study is to determine whether unrecognized maternal hyperglycemia and postprandial lipemia early or late in gestation predicts excess neonatal adiposity.NCT00826904·Aurora, Colorado

CompletedDose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDACThis is a Phase 1, open label, multi center, multiple dose, dose escalation, safety, pharmacokinetic and pharmacodynamic study of palbociclib in combination with nab-P, in…NCT02501902·Scottsdale, Arizona and 25 others

PreviousPage 133 of 829Next

in Colorado

Heart Diseasein Colorado